Mylan Posts Loss, Hurt by Lower EpiPen Volumes, Charge Related to Settlement

Mylan swung to a quarterly loss as it booked a big charge related to a settlement with authorities on contentious pricing of its EpiPen, and revenue growth came in below expectations as volumes of the lifesaving auto-injector fell.
Source: WSJ.com: Health - Category: Pharmaceuticals Tags: PAID Source Type: news